Arcadia Biosciences, Inc. (RKDA) Operating income 2017–2025
Arcadia Biosciences, Inc. (RKDA) annual operating income history from SEC filings — each fiscal year as reported.
-$2.5MFY2025 · since FY2017: -$14.3M → -$2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.5M | +31.5% |
| FY2024 | -$3.6M | +40.2% |
| FY2023 | -$6.1M | +56.4% |
| FY2022 | -$14.0M | +60.6% |
| FY2021 | -$35.5M | -178.0% |
| FY2020 | -$12.8M | +34.1% |
| FY2019 | -$19.4M | -14.9% |
| FY2018 | -$16.9M | -17.8% |
| FY2017 | -$14.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice